Rapid Cognitive Deterioration and Related Factors in Progressive Supranuclear Palsy: a One-Year Follow-up Study
Objective: Based on a relatively large cohort, we aimed to show the switch of cognitive status in patients with progressive supranuclear palsy (PSP) after one-year follow-up…A Systematic Review of Transcranial Magnetic Stimulation Clinical Trials in Parkinson’s Disease Patients with Mild Cognitive Impairment
Objective: This systematic review evaluated the efficacy of transcranial magnetic stimulation (TMS) for mild cognitive impairment in idiopathic Parkinson’s disease (iPD) through review of parallel…Periodic and Aperiodic EEG Correlates of Cognition in Parkinson’s Disease
Objective: To examine periodic and aperiodic EEG correlates of cognition in Parkinson’s disease (PD). Background: Quantitative EEG metrics are increasingly used to describe variations in…“This Abstract Presents the Most Important Scientific ___.” A New Sentence Completion Test for Parkinson’s Disease.
Objective: In this study we examined psychometric properties of a brief language and executive function measure in People with Parkinson’s (PwP) and related disorders. Background:…Split-belt Treadmill Training to Rehabilitate Freezing of Gait and Balance in Parkinson’s Disease
Objective: Can repeated exposure to a split-belt treadmill (SBTM) encourage motor learning to improve freezing of gait (FOG) and reduce the number of falls in…The dementia with Lewy bodies related metabolic brain pattern (DLBRP) – a multicentric validation
Objective: Dementia with Lewy bodies-related pattern (DLBRP) has been identified from the FDG PET brain imaging of DLB patients and healthy controls previously. A multicentric…How does the PPP2R2B mutation alter neuronal cytoskeletal structure in SCA12
Objective: To study the effect of the PPP2R2B mutation on human induced pluripotent stem cell (iPSC) derived neurons in SCA12 patients. Background: SCA12 is an…Association between use of Furosemide and Risk of Parkinson’s disease
Objective: Main objective of study is to check the association between furosemide use and risk of Parkinson's disease (PD) in a Finnish nationwide nested case-control…The impact of cognitive impairment and Alzheimer’s disease neuropathological changes on gait and falls in Parkinson’s disease
Objective: To investigate the association between clinical markers of cognitive impairment, severity, and distribution of Alzheimer's disease neuropathological changes (ADNC) with gait difficulties, freezing of…Clinical and Neuroimaging Biomarker Predictors of Cognitive Dysfunction In Parkinson’s Disease: A Study Using PPMI Data
Objective: This study evaluates whether clinical, biological, and neuroimaging baseline markers can predict the onset of significant cognitive-based milestones developed in these cohorts over a…
- 1
- 2
- 3
- …
- 117
- Next Page »